Potential neurological manifestations of COVID-19: a narrative review

References

• Di Carlo DT, Montemurro N, Petrella G, et al. Exploring the clinical association between neurological symptoms and COVID-19 pandemic outbreak: a systematic review of current literature. J Neurol. 2020;1–9.
   Web of Science ®Google Scholar
• Yu F, Du L, Ojcius DM, et al. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes Infect. 2020;22(2):74–79.
   PubMed Web of Science ®Google Scholar
• Song Z, Xu Y, Bao L, et al. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses. 2019;11(1):1.
   Web of Science ®Google Scholar
• Li Y-C, Bai W-Z, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92(6):552–555.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Cao D, Zhang Y, et al. Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat Commun. 2017;8(1):15092.
   PubMed Web of Science ®Google Scholar
• Hulswit RJ, de Haan CA, Bosch BJ. Coronavirus spike protein and tropism changes. Adv Virus Res. 2016;96:29–57.
   PubMed Web of Science ®Google Scholar
• Lai SL, Hsu MT, Chen SS. The impact of SARS on epilepsy: the experience of drug withdrawal in epileptic patients. Seizure. 2005;14(8):557–561.
   PubMed Web of Science ®Google Scholar
• Lippi A, Domingues R, Setz C, et al. SARS-CoV-2: at the crossroad between aging and neurodegeneration. Mov Disord. 2020;35(5):716–720.
   PubMed Web of Science ®Google Scholar
• Joob B, Wiwanitkit V. Neurologic syndrome due to MERS: is there a possibility that the virus can cross the blood-brain barrier to cause a neurological problem? Ann Trop Med Public Health. 2015;8(5):231.
   Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Jama. 2020;323(11):1061.
   Web of Science ®Google Scholar
• Field H. Bats and emerging zoonoses: henipavirus and SARS. Zoonoses. Public Health. 2009;56:278–284.
   Web of Science ®Google Scholar
• Bale JF Jr. Emerging viral infections. Semin Pediatr Neurol. 2012;19(3):152–157.
   PubMed Web of Science ®Google Scholar
• Pfefferle S, Oppong S, Drexler JF, et al. Distant relatives of severe acute respiratory syndrome coronavirus and close relatives of human coronavirus 229E in bats, Ghana. Emerg Infect Dis. 2009;15(9):1377–1384.
   PubMed Web of Science ®Google Scholar
• Williams S A brief history of human coronaviruses. The Scientist. The Scientist Web site. Published 2020 [cited 2020 Oct 12]. https://www.the-scientist.com/news-opinion/a-brief-history-of-human-coronaviruses-67600
   Google Scholar
• Algahtani H, Subahi A, Shirah B. Neurological complications of middle east respiratory syndrome coronavirus: a report of two cases and review of the literature. Case Rep Neurol Med. 2016;2016:3502683.
   PubMed Web of Science ®Google Scholar
• Ghannam M, Alshaer Q, Al-Chalabi M, et al. Neurological involvement of coronavirus disease 2019: a systematic review. J Neurol. 2020;267(11):3135-3153.
   PubMed Web of Science ®Google Scholar
• Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574.
   PubMed Web of Science ®Google Scholar
• Wan Y, Shang J, Graham R, et al. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J Virol. 2020;94(7). DOI:10.1128/JVI.00127-20
   Web of Science ®Google Scholar
• Walls AC, Park Y-J, Tortorici MA, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281–292.e286.
   PubMed Web of Science ®Google Scholar
• Qing E, Hantak MP, Galpalli GG, et al. Evaluating MERS-CoV entry pathways. Methods Mol Biol. 2020;2099:9–20.
   PubMedGoogle Scholar
• Carod-Artal FJ. Neurological complications of coronavirus and COVID-19. Rev Neurol. 2020;70(9):311–322.
   PubMed Web of Science ®Google Scholar
• Papa SM, Brundin P, Fung VSC, et al. Impact of the COVID-19 pandemic on Parkinson’s disease and movement disorders. Mov Disord. 2020;35(5):711-715.
   Google Scholar
• Matsuda K, Park CH, Sunden Y, et al. The vagus nerve is one route of transneural invasion for intranasally inoculated influenza a virus in mice. Vet Pathol. 2004;41(2):101–107.
   PubMed Web of Science ®Google Scholar
• Nicholson TW, Talbot NP, Nickol A, et al. Respiratory failure and non-invasive respiratory support during the covid-19 pandemic: an update for re-deployed hospital doctors and primary care physicians. BMJ (Clin Res Ed). 2020;369:m2446.
   PubMed Web of Science ®Google Scholar
• Turtle L. Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2. J Med Virol. 2020;92(7):705–706.
   PubMed Web of Science ®Google Scholar
• Griffin DE. Immune responses to RNA-virus infections of the CNS. Nat Rev Immunol. 2003;3(6):493–502.
   PubMed Web of Science ®Google Scholar
• Miner JJ, Diamond MS. Mechanisms of restriction of viral neuroinvasion at the blood-brain barrier. Curr Opin Immunol. 2016;38:18–23.
   PubMed Web of Science ®Google Scholar
• Desforges M, Le Coupanec A, Brison E, et al. Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans. Adv Exp Med Biol. 2014;807:75–96.
   PubMed Web of Science ®Google Scholar
• Partinen M, Kornum BR, Plazzi G, et al. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol. 2014;13(6):600–613.
   PubMed Web of Science ®Google Scholar
• Najjar S, Najjar A, Chong DJ, et al. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation. 2020;17(1):231.
   PubMed Web of Science ®Google Scholar
• Zaki AM, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814–1820.
   PubMed Web of Science ®Google Scholar
• Kim CJ, Choi WS, Jung Y, et al. Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity. Clin Microbiol Infect. 2016;22(10):880–886.
   PubMed Web of Science ®Google Scholar
• Kim JE, Heo JH, Kim HO, et al. Neurological complications during treatment of middle east respiratory syndrome. J Clin Neurol. 2017;13(3):227–233.
   PubMed Web of Science ®Google Scholar
• Saad M, Omrani AS, Baig K, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis. 2014;29:301–306.
   PubMed Web of Science ®Google Scholar
• Tsai LK, Hsieh ST, Chang YC. Neurological manifestations in severe acute respiratory syndrome. Acta Neurol Taiwan. 2005;14(3):113–119.
   PubMedGoogle Scholar
• Arbour N, Ekande S, Cote G, et al. Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E. J Virol. 1999;73(4):3326–3337.
   PubMed Web of Science ®Google Scholar
• Gu J, Gong E, Zhang B, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202(3):415–424.
   PubMed Web of Science ®Google Scholar
• Ding Y, Wang H, Shen H, et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol. 2003;200(3):282–289.
   PubMed Web of Science ®Google Scholar
• Xu J, Zhong S, Liu J, et al. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin Infect Dis. 2005;41(8):1089–1096.
   PubMed Web of Science ®Google Scholar
• Netland J, Meyerholz DK, Moore S, et al. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82(15):7264–7275.
   PubMed Web of Science ®Google Scholar
• Li K, Wohlford-Lenane C, Perlman S, et al. Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J Infect Dis. 2016;213(5):712–722.
   PubMed Web of Science ®Google Scholar
• McCray PB Jr., Pewe L, Wohlford-Lenane C, et al. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J Virol. 2007;81(2):813–821.
   PubMed Web of Science ®Google Scholar
• Hwang CS. Olfactory neuropathy in severe acute respiratory syndrome: report of A case. Acta Neurol Taiwan. 2006;15(1):26–28.
   PubMedGoogle Scholar
• Chao CC, Tsai LK, Chiou YH, et al. Peripheral nerve disease in SARS:: report of a case. Neurology. 2003;61(12):1820–1821.
   PubMed Web of Science ®Google Scholar
• Hung EC, Chim SS, Chan PK, et al. Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem. 2003;49(12):2108–2109.
   PubMed Web of Science ®Google Scholar
• Lau KK, Yu WC, Chu CM, et al. Possible central nervous system infection by SARS coronavirus. Emerg Infect Dis. 2004;10(2):342–344.
   PubMed Web of Science ®Google Scholar
• Tsai LK, Hsieh ST, Chao CC, et al. Neuromuscular disorders in severe acute respiratory syndrome. Arch Neurol. 2004;61(11):1669–1673.
   PubMedGoogle Scholar
• Fitzgerald S. The spread of COVID-19: questions raised, some answered by neuroinfectious disease experts. Neurol Today. 2020;20(7):1,25–26.
   Google Scholar
• Jin H, Hong X, Chen S, et al. Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists. Stroke Vasc Neurol. 2020;5(2):146–151.
   Google Scholar
• Abboud H, Abboud FZ, Kharbouch H, et al. COVID-19 and SARS-Cov-2 infection: pathophysiology and clinical effects on the nervous system. World Neurosurg. 2020;140:49–53.
   PubMed Web of Science ®Google Scholar
• Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: A systematic review. J Neurol Sci. 2020;413:116832.
   PubMed Web of Science ®Google Scholar
• Mao L, Wang M, Chen S, et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. medRxiv. 2020;77(6):683-690.
   Google Scholar
• Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251–2261.
   Web of Science ®Google Scholar
• Printza A, Constantinidis J. The role of self-reported smell and taste disorders in suspected COVID‑19. Eur Arch Otorhinolaryngol. 2020;277(9):2625–2630.
   PubMed Web of Science ®Google Scholar
• Tong JY, Wong A, Zhu D, et al. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2020;163(1):3–11.
   PubMed Web of Science ®Google Scholar
• Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55–58.
   PubMed Web of Science ®Google Scholar
• Hanna Huang Y, Jiang D, Huang JT. A case of COVID-19 encephalitis. Brain Behav Immun. 2020;87:149.
   PubMed Web of Science ®Google Scholar
• To KF, Lo AW. Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2). J Pathol. 2004;203(3):740–743.
   PubMed Web of Science ®Google Scholar
• Tang JW, To KF, Lo AW, et al. Quantitative temporal-spatial distribution of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) in post-mortem tissues. J Med Virol. 2007;79(9):1245–1253.
   PubMed Web of Science ®Google Scholar
• Kam YW, Okumura Y, Kido H, et al. Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro. PLoS One. 2009;4(11):e7870.
   PubMed Web of Science ®Google Scholar
• Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000;87(5):E1–9.
   PubMed Web of Science ®Google Scholar
• Hamming I, Timens W, Bulthuis M, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–637.
   PubMed Web of Science ®Google Scholar
• Boonacker E, Van Noorden CJ. The multifunctional or moonlighting protein CD26/DPPIV. Eur J Cell Biol. 2003;82(2):53–73.
   PubMed Web of Science ®Google Scholar
• Bernstein HG, Dobrowolny H, Keilhoff G, et al. Dipeptidyl peptidase IV, which probably plays important roles in Alzheimer disease (AD) pathology, is upregulated in AD brain neurons and associates with amyloid plaques. Neurochem Int. 2018;114:55–57.
   PubMed Web of Science ®Google Scholar
• Li YC, Bai WZ, Hirano N, et al. Coronavirus infection of rat dorsal root ganglia: ultrastructural characterization of viral replication, transfer, and the early response of satellite cells. Virus Res. 2012;163(2):628–635.
   PubMed Web of Science ®Google Scholar
• Li YC, Bai WZ, Hirano N, et al. Neurotropic virus tracing suggests a membranous-coating-mediated mechanism for transsynaptic communication. J Comp Neurol. 2013;521(1):203–212.
   PubMed Web of Science ®Google Scholar
• Andries K, Pensaert MB. Immunofluorescence studies on the pathogenesis of hemagglutinating encephalomyelitis virus infection in pigs after oronasal inoculation. Am J Vet Res. 1980;41(9):1372–1378.
   PubMed Web of Science ®Google Scholar
• Mengeling WL, Boothe AD, Ritchie AE. Characteristics of a coronavirus (strain 67N) of pigs. Am J Vet Res. 1972;33(2):297–308.
   PubMed Web of Science ®Google Scholar
• Khan S, Ali A, Siddique R, et al. Novel coronavirus is putting the whole world on alert. J Hosp Infect. 2020;104(3):252–253.
   PubMed Web of Science ®Google Scholar
• Guidon AC, Amato AA. COVID-19 and neuromuscular disorders. Neurology. 2020;94(22):959–969.
   PubMed Web of Science ®Google Scholar
• Paterson RW, Brown RL, Benjamin L, et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020. DOI:10.1093/brain/awaa240
   Web of Science ®Google Scholar
• Varatharaj A, Thomas N, Ellul MA, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020;7(10):875–882.
   Web of Science ®Google Scholar
• Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95(8):e1060-e1070.
   PubMed Web of Science ®Google Scholar
• Filatov A, Sharma P, Hindi F, et al. Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus. 2020;12(3):e7352.
   PubMed Web of Science ®Google Scholar
• Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422.
   PubMed Web of Science ®Google Scholar
• Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
   Web of Science ®Google Scholar
• Kotfis K, Williams Roberson S, Wilson JE, et al. COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Crit Care. 2020;24(1):176.
   PubMed Web of Science ®Google Scholar
• A SPECIAL MEETING REVIEW EDITION: Highlights in Crohn’s Disease and Ulcerative Colitis: Digestive Disease Week 2012 May 19-22. 2012 * San Diego, CaliforniaSpecial Reporting on:* Safety and efficacy of subcutaneous golimumab induction therapy in patients with moderately to severely active UC: PURSUIT-SC* The future of IBD therapy: individualized and optimized therapy and novel mechanisms* Infliximab concentration and clinical outcome in patients with UC* Vedolizumab induction therapy for UC: results of GEMINI I, a randomized, placebo-controlled, double-blind, multicenter, phase III trial* novel infliximab and antibody-to-infliximab assays are predictive of disease activity in patients with CD* accelerated step-care therapy with early azathioprine versus conventional step-care therapy in CD* PIANO: a 1,000-patient prospective registry of pregnancy outcomes in women with IBD exposed to immunomodulators and biologic TherapyPLUS meeting abstract summaries with expert commentary by: William J. Sandborn, MD chief of the Division of Gastroenterology Director of the UCSD IBD Center UC San Diego Health System La Jolla, California. Gastroenterol Hepatol. 2012;8(8 Suppl 5):1–24.
   Google Scholar
• Han JH, Zimmerman EE, Cutler N, et al. Delirium in older emergency department patients: recognition, risk factors, and psychomotor subtypes. Acad Emerg Med. 2009;16(3):193–200.
   PubMed Web of Science ®Google Scholar
• Francis J, Martin D, Kapoor WN. A prospective study of delirium in hospitalized elderly. Jama. 1990;263(8):1097–1101.
   PubMed Web of Science ®Google Scholar
• Elie M, Rousseau F, Cole M, et al. Prevalence and detection of delirium in elderly emergency department patients. Cmaj. 2000;163(8):977–981.
   PubMed Web of Science ®Google Scholar
• Spronk PE, Riekerk B, Hofhuis J, et al. Occurrence of delirium is severely underestimated in the ICU during daily care. Intensive Care Med. 2009;35(7):1276–1280.
   PubMed Web of Science ®Google Scholar
• Beach SR, Praschan NC, Hogan C, et al. Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement. Gen Hosp Psychiatry. 2020;65:47–53.
   PubMed Web of Science ®Google Scholar
• Werner C, Scullen T, Mathkour M, et al. Neurological impact of coronavirus disease (COVID-19): practical considerations for the neuroscience community. World Neurosurg. 2020;139:344–354.
   PubMed Web of Science ®Google Scholar
• Poyiadji N, Shahin G, Noujaim D, et al. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. 2020;296(2):E119-E120.
   Web of Science ®Google Scholar
• Ely EW, Gautam S, Margolin R, et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med. 2001;27(12):1892–1900.
   PubMed Web of Science ®Google Scholar
• Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. Jama. 2004;291(14):1753–1762.
   PubMed Web of Science ®Google Scholar
• Pandharipande PP, Girard TD, Jackson JC, et al. Long-term cognitive impairment after critical illness. N Engl J Med. 2013;369(14):1306–1316.
   PubMed Web of Science ®Google Scholar
• Abdel-Mannan O, Eyre M, Löbel U, et al. Neurologic and radiographic findings associated with COVID-19 infection in children. JAMA Neurol. 2020. DOI:10.1001/jamaneurol.2020.2687
   PubMed Web of Science ®Google Scholar
• Cao-Lormeau VM, Blake A, Mons S, et al. Guillain-Barre syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387(10027):1531–1539.
   PubMed Web of Science ®Google Scholar
• Abrams RMC, Kim BD, Markantone DM, et al. Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease. J Neurovirol. 2020; 26(5):797-799.
   PubMed Web of Science ®Google Scholar
• Toscano G, Palmerini F, Ravaglia S, et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574–2576.
   PubMed Web of Science ®Google Scholar
• Arnaud S, Budowski C, Ng Wing Tin S, et al. Post SARS-CoV-2 Guillain-Barré syndrome. Clin Neurophysiol. 2020;131(7):1652–1654.
   PubMed Web of Science ®Google Scholar
• Scheidl E, Canseco DD, Hadji-Naumov A, et al. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature. J Peripher Nerv Syst. 2020;25(2):204–207.
   PubMed Web of Science ®Google Scholar
• Zhao H, Shen D, Zhou H, et al. Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383–384.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Wang JT, Sheng WH, Fang CT, et al. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg Infect Dis. 2004;10(5):818–824.
   PubMed Web of Science ®Google Scholar
• Chen LL, Hsu CW, Tian YC, et al. Rhabdomyolysis associated with acute renal failure in patients with severe acute respiratory syndrome. Int J Clin Pract. 2005;59(10):1162–1166.
   PubMed Web of Science ®Google Scholar
• Ye M, Ren Y, Lv T. Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun. 2020;88:945–946.
   Web of Science ®Google Scholar
• Leitinger M, Beniczky S, Rohracher A, et al. Salzburg consensus criteria for non-convulsive status epilepticus–approach to clinical application. Epilepsy Behav. 2015;49:158–163.
   PubMed Web of Science ®Google Scholar
• Baker AM, Yasavolian MA, Arandi NR. Nonconvulsive status epilepticus: overlooked and undertreated. Emerg Med Pract. 2019;21(10):1–24.
   PubMedGoogle Scholar
• Trinka E, Leitinger M. Which EEG patterns in coma are nonconvulsive status epilepticus? Epilepsy Behav. 2015;49:203–222.
   PubMed Web of Science ®Google Scholar
• Román GC, Spencer PS, Reis J, et al. The neurology of COVID-19 revisited: A proposal from the environmental neurology specialty group of the world federation of neurology to implement international neurological registries. J Neurol Sci. 2020;414:116884.
   PubMed Web of Science ®Google Scholar
• Bolay H, Gül A, Baykan B. COVID-19 is a real headache! Headache. 2020;60(7):1415–1421.
   Web of Science ®Google Scholar
• Bobker SM, Robbins MS. COVID-19 and headache: A primer for trainees. Headache. 2020;60(8):1806–1811.
   PubMed Web of Science ®Google Scholar
• Zifko UA, Zipko HT, Bolton CF. Clinical and electrophysiological findings in critical illness polyneuropathy. J Neurol Sci. 1998;159(2):186–193.
   PubMed Web of Science ®Google Scholar
• Bolton CF. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med. 1996;24(8):1408–1416.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang M, Zou Y, et al. Acute cerebrovascular disease following COVID-19: a single, retrospective, observational study. Stroke Vasc Neurol 2020;5(3):279-284.
   Google Scholar
• Duvoisin RC, Yahr MD. Encephalitis and parkinsonism. Arch Neurol. 1965;12(3):227–239.
   PubMedGoogle Scholar
• Fazzini E, Fleming J, Fahn S. Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson’s disease. Mov Disord. 1992;7(2):153–158.
   PubMed Web of Science ®Google Scholar
• Wong GF, Gray CS, Hassanein RS, et al. Environmental risk factors in siblings with Parkinson’s disease. Arch Neurol. 1991;48(3):287–289.
   PubMedGoogle Scholar
• Koller W, Vetere-Overfield B, Gray C, et al. Environmental risk factors in Parkinson’s disease. Neurology. 1990;40(8):1218–1221.
   PubMed Web of Science ®Google Scholar
• Prasad S, Holla VV, Neeraja K, et al. Parkinson’s disease and COVID-19: perceptions and implications in patients and caregivers. Mov Disord. 2020;35(6):912–914.
   Web of Science ®Google Scholar
• Helmich RC, Bloem BR. The impact of the COVID-19 pandemic on Parkinson’s disease: hidden sorrows and emerging opportunities. J Parkinsons Dis. 2020;10(2):351–354.
   PubMedGoogle Scholar
• Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92(6):552-555.
   Web of Science ®Google Scholar
• Baig AM, Khaleeq A, Ali U, et al. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11(7):995–998.
   PubMed Web of Science ®Google Scholar
• Baig AM. Neurological manifestations in COVID-19 caused by SARS-CoV-2. CNS Neurosci Ther. 2020;26(5):499–501.
   PubMed Web of Science ®Google Scholar
• Swanson PA 2nd, McGavern DB. Viral diseases of the central nervous system. Curr Opin Virol. 2015;11:44–54.
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhao Y, Zhang F, et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China. Clin Immunol. 2020;214:108393.
   PubMed Web of Science ®Google Scholar
• Sanders JM, Monogue ML, Jodlowski TZ, et al. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. Jama. 2020. DOI:10.1001/jama.2020.6019
   PubMed Web of Science ®Google Scholar
• Needham EJ, Chou SH, Coles AJ, et al. Neurological implications of COVID-19 infections. Neurocrit Care. 2020;32(3):667–671.
   PubMed Web of Science ®Google Scholar
• Sheehy LM. Considerations for postacute rehabilitation for survivors of COVID-19. JMIR Public Health Surveill. 2020;6(2):e19462–e19462.
   PubMedGoogle Scholar
• Tramonti F, Bonfiglio L, Bongioanni P, et al. Caregiver burden and family functioning in different neurological diseases. Psychol Health Med. 2019;24(1):27–34.
   PubMed Web of Science ®Google Scholar
• Whiteford HA, Ferrari AJ, Degenhardt L, et al. The global burden of mental, neurological and substance use disorders: an analysis from the global burden of disease study 2010. PLoS One. 2015;10(2):e0116820.
   PubMed Web of Science ®Google Scholar
• Ding Y, He L, Zhang Q, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004;203(2):622–630.
   PubMed Web of Science ®Google Scholar